Clinical Trial Update: Personalized Vaccine for TNBC Immunotherapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a personalized vaccine for triple-negative breast cancer is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Personalized vaccine for triple-negative breast cancer

Snippet

Sponsor: Universidad Nacional de Colombia | Conditions: Breast Cancer Female | Phase 1 | Status: NOT_YET_RECRUITING